Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-032090

General Counsel sold 1,592 shares at an average $3.04 ($4,839)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-18 Sale : show line 1 in the form −1,004 $3.07 $3,077 136,050 D
2025-08-19 Sale : show line 2 in the form −588 $3.00 $1,762 135,462 D
Open-market sales · 1,592 sh · avg $3.04 · $4,839
Loading xslF345X05/form4.xml…